Authorship and Acknowledgements:
Based on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, by the ICMJE, Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript. Also each author should have participated sufficiently in the work to be responsible for its content.
Each author should meet all criteria (A, B, C, and D) that recommended by the ICMJE as following conditions:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors.
The authors also must certify that the manuscript represents valid data and has not been published in any form and is not being submitted for in the form of scientific presentations for publication elsewhere.
If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.
The contributors who do not meet the authorship criteria should be mentioned as “Acknowledgments”.
Changes in Authorship: The authors should be agreed the order of authorship among themselves before submitting the manuscript. Changes in authorship (ie, order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in a letter to the editor signed by all the authors or email from all authors.
 
Randomized control trials:
Randomized controlled trials must be according to The CONSORT Statement guideline.

Archiving policy
  All studies published in Iranian Journal of Diabetes and Obesity, along with their supplements, are freely and continuously accessible and stored on our website as well as in various international databases worldwide. This ensures long-term digital preservation through platforms such as  DOAJ, EBSCO, Index Copernicus, Islamic World Science Citation Center (ISC), Google Scholar Citation . Authors are advised to use the final PDF version from the journal's website for self-archiving. The Publisher permits authors to use the final published version of their articles for self-archiving. Additionally, all articles published in Iranian Journal of Diabetes and Obesity , are archived by Shahid Sadoughi University of Medical Sciences.

Conflicts of interest
All authors must inform us about any kinds of financial, personal, political, or academic "Conflict of Interest that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through: (http://www.icmje.org/coi_disclosure.pdf)
The editors of this journal are aware of the risk of conflict of interest in manuscript management and asked to disclose potential conflicts with the author (s), if any, to avoid any decisions influenced by relationships with the authors.
The IJDO requires referees to provide a fair assessment. As such, editors must ensure that reviewers do not have a conflict of interest, which prevents reviewers from acting unfairly. When referees are invited to review a manuscript, they are asked to consider any competing interests about the submitted article. The journal asks the reviewers to refrain from reviewing a paper if there is any conflict. Also, reviewers are prohibited from using the article they are reviewing before its publication for their own benefit.

Confidentiality  
The journal upholds strict confidentiality standards throughout the review and publication process. All manuscripts, reviewer identities, and correspondence are treated as confidential materials. Editorial Board members and reviewers are prohibited from disclosing any details of a submitted manuscript to parties outside the peer review process without explicit authorization from the Editor-in-Chief.

Appeals and Complaints  
Authors who wish to appeal editorial decisions or submit a complaint regarding the editorial or peer review process may do so by contacting the Editorial Office in email. All appeals and complaints are reviewed by the Editor-in-Chief or an independent senior editor not involved in the original decision. The journal ensures that all appeals are handled transparently and impartially.

Data Sharing  
Authors are encouraged to make research data supporting their published findings available through recognized data repositories, in accordance with FAIR (Findable, Accessible, Interoperable, Reusable) principles. Data availability statements must be included in the manuscript. The journal endorses open data sharing to foster reproducibility and transparency in research, while respecting privacy and ethical considerations.

Artificial Intelligence  
The use of artificial intelligence tools in research and manuscript preparation must be clearly disclosed. AI-generated content cannot be listed as an author, and authors are fully accountable for the accuracy and integrity of all content produced with AI assistance. The journal follows COPE and international publishing guidelines for the responsible use of AI in scholarly communication.

Direct Marketing  
The journal adheres to ethical direct marketing practices. Communication with authors, reviewers, and subscribers is limited to relevant academic, editorial, or promotional announcements directly related to the journal’s mission. Personal information will not be shared with third parties for commercial marketing purposes.

Research Misconduct  
Research misconduct—including fabrication, falsification, plagiarism, image manipulation, and unethical authorship practices—is strictly prohibited. Suspected cases are investigated in accordance with COPE guidelines and relevant institutional policies. Confirmed misconduct may result in manuscript rejection, retraction, and notification of the author’s institution or funding body.

Retraction Policy
The IJDO for retraction of a published article uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). 
All manuscripts submitted to IJDO will be checked after submission and Before Publication in Terms of Plagiarism using specific software. Submission of a paper implies that it reports unpublished results that are not under consideration for publication elsewhere. If previously published tables, illustrations, or texts are included, this should be clearly indicated in the manuscript and the copyright holder’s permission must be obtained. Previously published materials can be cited in a later review or commentary article, but it must be indicated using quotation marks if necessary.

Correction and Retraction Policy  
The journal is committed to maintaining the accuracy and integrity of the published record. Necessary corrections will be issued promptly when errors are identified. In cases of significant errors or research misconduct, the Editorial Board may issue a retraction or expression of concern, following COPE recommendations. All corrections, retractions, and related updates are made accessible online and linked to the original publication.